 
                        | Product NDC: | 0406-8330 | 
| Proprietary Name: | MORPHINE SULFATE | 
| Non Proprietary Name: | MORPHINE SULFATE | 
| Active Ingredient(s): | 30 mg/1 & nbsp; MORPHINE SULFATE | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, EXTENDED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0406-8330 | 
| Labeler Name: | Mallinckrodt, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA076412 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20101021 | 
| Package NDC: | 0406-8330-62 | 
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8330-62) | 
| NDC Code | 0406-8330-62 | 
| Proprietary Name | MORPHINE SULFATE | 
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8330-62) | 
| Product NDC | 0406-8330 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | MORPHINE SULFATE | 
| Dosage Form Name | TABLET, EXTENDED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20101021 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Mallinckrodt, Inc. | 
| Substance Name | MORPHINE SULFATE | 
| Strength Number | 30 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |